Onderneming Forma Therapeutics Holdings, Inc.
Aandelen
FMTX
US34633R1041
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 189
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Shegog
DFI | Director of Finance/CFO | 59 | 01-09-19 |
President | - | 14-10-22 | |
David N. Cook
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-04-20 |
Mario Corso
IRC | Investor Relations Contact | - | 01-09-20 |
Ifeyinwa Osunkwo
PRN | Corporate Officer/Principal | - | 01-01-22 |
Ruth du Moulin
PRN | Corporate Officer/Principal | - | 16-09-20 |
Jeannette Potts
LAW | General Counsel | 62 | 01-09-19 |
Mary Wadlinger
HRO | Human Resources Officer | 64 | 11-09-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Haagen
BRD | Director/Board Member | 58 | 14-10-22 |
President | - | 14-10-22 | |
Steve Benz
BRD | Director/Board Member | - | 14-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 47 856 812 | 45 795 107 ( 95,69 %) | 4 255 ( 0,008891 %) | 95,69 % |
Bedrijfsgegevens
Forma Therapeutics Holdings, Inc.
300 North Beacon Street Suite 501
02472, Watertown
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,82% | 41,35 mld. | |
+42,72% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |